Glenmark Pharmaceuticals

BSE : 532296 | NSE : GLENMARK

Industry : Pharmaceuticals | ISIN : INE935A01035 | FreeFloat : 55.00% | FnO : Yes | LotSize : 2300


Intellectual Capital (IC)4,258.82
Net Worth (NW)6,070.11
Intrinsic Worth (IW)10,328.93
Market Cap (MC)5,808.43
Economic Value Added-45.12
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)41.23%
IC Gross Margin (EBITDA/IC)43.30%
IC Net Margin (NPT/IC)12.00%
Knowledge Turnover (Sales/IC)2.41
Market to Intrinsic Value (MC/IW)0.56

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 366.06Rs. 205.85
3 Aug 2020 - Rs. 449.80
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 428.86ReduceSell
KB > 50% : No50 DMA : Rs. 417.30
0 < M2IV < 1 : YesVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
C
2363.00
2378.29
592.74
515.00
444.14
333.38
296.78
Sep-17
C
2256.59
2286.32
409.12
333.89
273.05
214.12
217.61
Dec-17
C
2203.07
2180.50
299.53
224.15
153.67
104.74
114.90
Mar-18
C
2279.82
2349.37
263.26
255.91
248.47
151.63
100.58
Jun-18
C
2165.62
2303.83
485.10
390.62
311.61
222.78
-50.68
Sep-18
C
2581.33
2721.19
747.15
653.78
568.66
222.78
363.29
Dec-18
C
2555.05
2446.03
325.67
242.56
154.03
116.34
166.19
Mar-19
C
2563.47
2602.53
403.19
322.22
240.31
161.66
12.92
Jun-19
C
2322.88
2324.55
343.58
252.85
159.84
109.28
149.29
Sep-19
C
2815.04
2895.87
531.23
437.07
347.30
255.54
139.19
Dec-19
C
2735.56
2768.52
473.04
367.04
270.98
190.84
221.14
Mar-20
C
2767.49
2811.63
542.71
416.43
317.96
220.31
20.64
* C - Consolidated, S - Standalone